Access Bio, Inc.

Company Profile

Sector

Healthcare

Industry

Diagnostics & Research

Employees

N/A

Website

accessbio.net

Country

United States

Exchange

KOSDAQ

Somerset, New Jersey

Access Bio provides the research, development, and manufacture of in vitro rapid diagnostic tests, immunochemical diagnostics, biosensors, and molecular diagnostic products globally. The company provides Covid-19 detection kits, which are tests for assessing the current or past presence of SARS-CoV-2..

Its portfolio also includes rapid diagnostic tests, suitable for preliminary diagnosis or emergency medical screening in medical facilities with limited resources, analyzers, designed to measure different chemicals and characteristics in biological samples, and molecular diagnostic solutions used in analyzing biological markers in the genome and proteome. It offers its products under CareStart, CareUS, CareSURE, and CareGENE brand names. Incorporated in 2002, the company is headquartered in Somerset, New Jersey.

Key Stats

52-Week Range

₩1957.00₩5570.00

Beta0.25

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.